Anti-CTLA-4 monoclonal antibodies

Yervoy 200 mg/40 mL injection Images

Generic Name: ipilimumab

This medication has been identified as Yervoy 200 mg/40 mL injection. It is supplied by Bristol-Myers Squibb Company.

Yervoy is used in the treatment of Melanoma, Metastatic; Melanoma; Renal Cell Carcinoma; Colorectal Cancer; Malignant Pleural Mesothelioma and belongs to the drug class anti-CTLA-4 monoclonal antibodies. Risk cannot be ruled out during pregnancy. Yervoy 200 mg/40 mL injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Yervoy (Ipilimumab [ ip-i-lim-ue-mab ])-medicine-200 mg/40 mL injection

Yervoy
Generic Name: ipilimumab [ ip-i-lim-ue-mab ]
Imprint: medicine
Strength: 200 mg/40 mL injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: Anti-CTLA-4 monoclonal antibodies
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00003-2328
Inactive Ingredients:
Latest News
Related Drugs